A new approach in insulin pump education improves glycemic outcomes: a randomized controlled trial

Karen Rytter*, Anette Hougaard, Anne Grynnerup Skouboe, Nermin Serifovski, Ajenthen Gayathri Ranjan, Kirsten Nørgaard

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Aims: To address the scarcity of continued education for insulin pump users, we developed and evaluated a new program (NP) for individuals transitioning to a different insulin pump. Methods: In a randomized, controlled 3-month study, adults with type 1 diabetes and suboptimal HbA1c received either NP or usual care program (UC). The NP was designed in collaboration with representatives of the target group and incorporated technical training, case-based learning, and peer experience sharing – encompassing two group sessions, and two follow-up telephone calls. The UC included a single training session led by the pump company with hotline assistance (clinic) but no structured follow-up. The primary endpoint was the difference in time in range (TIR) (70–180 mg/dL (3.9–10.0 mmol/L)), measured by continuous glucose monitoring from baseline to 3 months post-course. Psychosocial self-efficacy was measured by the Diabetes Empowerment Scale (DES-SF). Results: Thirty-nine participants (median age 43, 74% female) were included. Mean TIR increased significantly in the NP group and remained unchanged in the UC group (between-group difference in change was 13.5% [95% CI: 4.0 to 22.9], p = 0.0064). Psychosocial self-efficacy improved and HbA1c decreased only significantly in the NP group. Conclusions: Applying a novel education program at pump transition significantly improved glycemic outcomes and self-efficacy.

Original languageEnglish
JournalActa Diabetologica
ISSN0940-5429
DOIs
Publication statusAccepted/In press - 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Keywords

  • Diabetes self-management
  • Education
  • Empowerment
  • Insulin pump
  • Time in ranges
  • Type 1 diabetes

Cite this